Rubric Capital Management secured a board seat in TherapeuticsMD, Inc.(TXMD)
Key Summary: TherapeuticsMD, Inc. (Market Cap: $93M) appointed Rubric Capital's nominee, Justin Roberts, as an independent director on August 29, 2022, following Rubric's 18.3% stake and discussions with the company earlier that month.
Market Cap: $13 million | TherapeuticsMD, Inc. operates as a women's healthcare company in the United States.
- On August 8, 2022, Rubric Capital Management (18.3%) stated that it had discussions with the company and subsequently submitted Justin Roberts as a nominee for an independent director seat on the board. Source
- On August 29, 2022, the company appointed Justin Roberts as an independent director on its board of directors. Source
Member discussion